Evidence map›Paper›PMID 24011580›Full record

ReviewSeminars in nephrology2013

Epigenetics and the control of the collecting duct epithelial sodium channel.

Bruce C Kone

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in nephrology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Epigenetic modification in diabetic kidney disease.Frontiers in endocrinology · 2023
    Review
  2. Article
  3. Review
  4. Review
  5. Combined Salt and Caloric Restrictions: Potential Adverse Outcomes.Journal of the American Heart Association · 2017
    Article
  6. Coordinated Control of ENaC and Na+,K+-ATPase in Renal Collecting Duct.Journal of the American Society of Nephrology : JASN · 2016
    Review
  7. Review
  8. Inhibition of ENaC by endothelin-1.Vitamins and hormones · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Bruce C KoneDivision of Renal Diseases and Hypertension, Department of Internal Medicine, The University of Texas Medical School, Houston, TX. Electronic address: Bruce.C.Kone@uth.tmc.edu.
The University of Texas at Austin · US

Funding

Regulation of ENaC TranscriptionR01DK075065 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KONE, BRUCE C. · 2006 to 2013
$2.5M
NIDDK NIH HHS R01 DK075065
6 · The paper itself

Abstract

The apical membrane epithelial Na(+) channel subunit (ENaC) in series with the basolateral Na(+)/K(+)-adenosine triphosphatase mediates collecting duct Na(+) reabsorption. Aldosterone induces αENaC gene transcription, which appears to be rate limiting for ENaC activity in this segment. Although this response has long been assumed to be solely the result of liganded nuclear hormone receptors trans-activating αENaC, epigenetic controls of basal and aldosterone-induced transcription of αENaC in the collecting duct recently were described. These epigenetic pathways involve dynamic nuclear repressor complexes targeted to specific subregions of the αENaC promoter and consisting of the histone methyltransferase disrupter of telomeric silencing (Dot)1a together with the transcriptional factor Af9 or the nicotinamide adenine dinucleotide (NAD)-dependent protein deacetylase Sirt1, key co-regulatory proteins, including serum- and glucocorticoid-induced kinase-1 and the putative transcription factor Af17, and targeted chromatin modifications. The complexes, through the action of Dot1a, maintain chromatin associated with the αENaC promoter in a stable hypermethylated state, constraining αENaC transcription under basal conditions. Aldosterone and serum- and glucocorticoid-induced kinase-1, itself, activate αENaC transcription in large part by disrupting or diminishing the Dot1a-Af9 and Dot1a-Sirt1 complexes and their effects on chromatin. Mouse models indicate potential roles of the Dot1a pathways in renal salt excretion and hypertension.

Indexed as

Epigenesis, GeneticAldosteroneAnimalsBlood PressureEpithelial Sodium ChannelsHistone-Lysine N-MethyltransferaseHumansKidney Tubules, CollectingMethyltransferasesPromoter Regions, GeneticSirtuin 1AldosteroneDOT1L protein, humanEpithelial Sodium ChannelsHistone-Lysine N-MethyltransferaseMethyltransferasesSIRT1 protein, humanSirtuin 1blood pressurechromatinepithelial sodium channelGene transcriptionhistone

Identifiers

PMID24011580
PMCPMC3767935
OpenAlexW2004146267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.